Anthropometric trajectories of Korean children and adolescents with severe obesity

Jeongho Han1, Hakyung Lee1, Dong Jun Ha1

  • 1Department of Pediatrics, Seoul National University Bundang Hospital, Seongnam, Korea.

Insights

Lifestyle changes modestly reduced BMI z scores in severely obese children, but most remained obese with few metabolic improvements. Early, intensive interventions are crucial for pediatric obesity management.

Area of Science:

  • Pediatric Endocrinology
  • Obesity Medicine
  • Public Health

Background:

  • Severe pediatric obesity presents a growing global health challenge, particularly in South Korea.
  • It is strongly linked to metabolic and cardiovascular complications.
  • Limited longitudinal data exist for Korean children experiencing severe obesity.

Purpose of the Study:

  • To assess changes in Body Mass Index (BMI) and metabolic syndrome components in children and adolescents with severe obesity.
  • To evaluate outcomes of management solely through lifestyle modifications, excluding pharmacological or surgical interventions.

Main Methods:

  • Retrospective review of 124 participants (age <18) with severe obesity (BMI ≥120% of 95th percentile) from 2017-2024.
  • Inclusion criteria required over 1 year of follow-up; management focused on lifestyle changes (nutrition, physical activity, sleep, screen time).
  • Primary outcome: change in BMI z-score; secondary analysis explored predictors of BMI z-score change.

Main Results:

  • A modest mean decrease in BMI z-scores was observed (from 3.68±0.75 to -0.27±0.79, P<0.001) over a mean follow-up of 2.64 years.
  • Younger age and male sex were associated with greater BMI z-score reductions.
  • Most participants remained severely obese, with only modest improvements in liver transaminases and no significant changes in other metabolic syndrome components.

Conclusions:

  • Lifestyle modifications led to a small reduction in BMI z-scores for severely obese children, but did not resolve severe obesity or significantly improve most metabolic health markers.
  • Findings highlight the urgent need for early and more intensive interventions to effectively manage pediatric obesity and its associated health risks.
Abstract

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.6K
Signs of Puberty01:27

Signs of Puberty

Puberty is a critical phase, typically beginning between the ages of 8 and 13 in girls and 9 and 14 in boys, though timing can vary based on genetics, environmental factors, and overall health. This period is characterized by the development of secondary sexual characteristics and the attainment of reproductive potential. Endocrine changes underpin puberty, with hormonal surges of Luteinizing Hormone (LH) and Follicle-Stimulating Hormone (FSH) instigated by Gonadotropin-Releasing Hormone (GnRH)...
2.1K
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
419
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
307
Nature and Nurture01:10

Nature and Nurture

Many human characteristics, like height, are shaped by both nature—in other words, by our genes—and by nurture, or our environment. For example, chronic stress during childhood inhibits the production of growth hormones and consequently reduces bone growth and height. Scientists estimate that 70-90% of variation in height is due to genetic differences among individuals, and 10-30% of variation in height is due to differences in the environments that individuals experience,...
23.1K
Anorexia Nervosa01:28

Anorexia Nervosa

Anorexia nervosa is a complex and severe eating disorder characterized by an intense fear of weight gain, an unrelenting pursuit of thinness, and a distorted body image. It often leads to dangerously low body weight relative to an individual's age and height. This disorder is marked by significant physical and psychological consequences, making it one of the most life-threatening psychiatric illnesses.
Symptoms and Physical Effects
Individuals with anorexia nervosa commonly exhibit extreme...
2.1K